Browsing by Author Clark, Susan J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2014Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Castillo, Lesley; Chiam, K; Clark, Susan J.; Daly, R; Lee, B Y; Lin, H-M; Mallesara, G; Nguyen, Q; Swarbrick, A.; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreCirculating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer, British Journal of Cancer, vol.110, 10, 2014,pp 2462-2471
2007Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesisHuschtscha, Lily; Reddel, Roger R; Abdipranoto, Andrea; Clark, Susan J.; Hinshelwood, Rebecca A.; Hume, David A.; Melki, John; Ravasi, Timothy; Stirzaker, Clare; Vissel, Bryce; Wells, Christine A.; Concord Clinical School: Age & Alzh Dis Rrch Educ; Children's Hospital Westmead: Childrens Medical Research InsConcordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis, Cancer Research, vol.67,(24),2007,pp 11517-11527
2015Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesisReddel, Roger; Clark, Susan J.; Hinshelwood, Rebecca A.; Huschtscha, Lily I; Locke, W; Robinson, Mark D; Stirzaker, Clare; Stone, Andrew; Zotenko, Elena; Childrens Medical Research Institute (CMRI)Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis, Clinical Epigenetics, vol.7, 1, 2015,pp 1-15
2009Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumoursClifton-Bligh, Roderick; Gill, Anthony; McDonald, Kerrie; Robinson, Bruce; Braund, Wilton; Burt, Morton G; Campbell, Kirsten; Clark, Susan J.; Cook, Raymond J.; Grossman, Ashley; Little, Nicholas S.; McCormack, Ann; Northern Clinical School: Medicine; Deans Unit: (CIPHER); School of Public Health: NH&MRC Clinical Trials Centre; Northern Clinical School: MedicineLow O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours, Clinical Endocrinology, vol.71, 2, 2009,pp 226-233
2014Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Stockler, Martin; Castillo, Lesley; Chatfield, Mark; Clark, Susan J.; Devaney, James; Mallesara, G; Molloy, Peter; Paul, Cheryl; Qu, W; Wykes, R J; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; School of Public Health: NH&MRC Clinical Trials CentreMethylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer, British Journal of Cancer, vol.111, 9, 2014,pp 1802-1809